We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$15B
AUM Growth
+$614M
Cap. Flow
-$689M
Cap. Flow %
-4.6%
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$86.4M
2
SAGE
Sage Therapeutics
SAGE
+$56.2M
3
WEC icon
WEC Energy
WEC
+$49.5M
4
AOS icon
A.O. Smith
AOS
+$48.9M
5
CHRW icon
C.H. Robinson
CHRW
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 17.37%
3 Industrials 15.16%
4 Consumer Discretionary 13.51%
5 Financials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
226
Xylem
XYL
$27.3B
$23.3M 0.16%
295,879
-25,600
-8% -$1.99M
CNK icon
227
Cinemark Holdings
CNK
$4.19B
$23.2M 0.16%
685,334
-13,398
-2% -$474K
WFC icon
228
Wells Fargo
WFC
$258B
$23.1M 0.15%
429,283
+80,620
+23% +$4.22M
ZS icon
229
Zscaler
ZS
$24B
$23.1M 0.15%
+495,750
New +$23M
LMT icon
230
Lockheed Martin
LMT
$132B
$23M 0.15%
58,950
-23,265
-28% -$8.93M
EVR icon
231
Evercore
EVR
$12.1B
$22.8M 0.15%
305,575
+52,675
+21% +$4.01M
KL
232
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$22.6M 0.15%
513,321
-380,779
-43% -$16.9M
SYY icon
233
Sysco
SYY
$40.6B
$22.6M 0.15%
264,326
-5,167
-2% -$419K
QURE icon
234
uniQure
QURE
$2.93B
$22.6M 0.15%
315,456
LAMR icon
235
Lamar Advertising Co
LAMR
$16.3B
$22.5M 0.15%
251,773
+96,575
+62% +$8.08M
OKE icon
236
Oneok
OKE
$56.1B
$22.4M 0.15%
296,550
-118,600
-29% -$8.48M
VMC icon
237
Vulcan Materials
VMC
$35.1B
$22.3M 0.15%
154,650
-10,275
-6% -$1.47M
PFE icon
238
Pfizer
PFE
$142B
$22.2M 0.15%
597,602
-11,683
-2% -$416K
LFUS icon
239
Littelfuse
LFUS
$11.2B
$22.1M 0.15%
115,457
LGF.A
240
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$22.1M 0.15%
2,070,055
-1,042,276
-33% -$9.6M
BEAT
241
DELISTED
BioTelemetry, Inc.
BEAT
$22.1M 0.15%
476,407
-4,200
-0.9% -$182K
PEP icon
242
PepsiCo
PEP
$191B
$22M 0.15%
160,768
-3,143
-2% -$428K
LLY icon
243
Eli Lilly
LLY
$1.03T
$21.3M 0.14%
162,144
-4,295
-3% -$498K
ADI icon
244
Analog Devices
ADI
$179B
$21.3M 0.14%
179,100
+47,350
+36% +$5.34M
VOYA icon
245
Voya Financial
VOYA
$9.09B
$21.2M 0.14%
347,512
-69,975
-17% -$3.95M
HUM icon
246
Humana
HUM
$44B
$21.1M 0.14%
57,630
+33,788
+142% +$10.7M
MPC icon
247
Marathon Petroleum
MPC
$91.7B
$21.1M 0.14%
349,425
+33,850
+11% +$2.12M
SRE icon
248
Sempra
SRE
$58.6B
$21M 0.14%
276,626
-5,408
-2% -$397K
PLD icon
249
Prologis
PLD
$136B
$20.9M 0.14%
233,981
-4,575
-2% -$406K
CPRT icon
250
Copart
CPRT
$27.4B
$20.9M 0.14%
917,100
-133,000
-13% -$2.84M

Similar funds

Carillon Tower Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Carillon Tower Advisers held 499 positions worth $15B, up 4.3% from $14.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Carillon Tower Advisers withdrew a net $689M in Q4 2019, closing 34 positions and reducing 287 holdings. Its most notable exit was Insulet, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in Seagen Inc. Common Stock worth $48.8M.

  • Carillon Tower Advisers's largest Q4 2019 buy was Seagen Inc. Common Stock: 426,867 shares worth $48.8M.
  • Carillon Tower Advisers added most to Corpay in Q4 2019, an estimated $58.8M increase.
  • Carillon Tower Advisers's biggest Q4 2019 reduction was WEC Energy, cutting an estimated $49.5M.
  • Carillon Tower Advisers fully exited Insulet in Q4 2019, selling an estimated $86.4M.
  • Carillon Tower Advisers's ten largest holdings make up 9.9% of its $15B portfolio in Q4 2019.
  • Carillon Tower Advisers opened 33 new positions and closed 34 in Q4 2019.
  • Carillon Tower Advisers's portfolio value rose 4.3% quarter-over-quarter to $15B.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.